Bone Cell Biology and Disease Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia.
Department of Genetics and Molecular Biology, University of Campinas, São Paulo, Brazil.
J Endocrinol. 2022 Sep 7;255(1):25-37. doi: 10.1530/JOE-22-0084. Print 2022 Oct 1.
Bone strength is partially determined during cortical bone consolidation, a process comprising coalescence of peripheral trabecular bone and its progressive mineralisation. Mice with genetic deletion of suppressor of cytokine signalling 3 (Socs3), an inhibitor of STAT3 signalling, exhibit delayed cortical bone consolidation, indicated by high cortical porosity, low mineral content, and low bone strength. Since leptin receptor (LepR) is expressed in the osteoblast lineage and is suppressed by SOCS3, we evaluated whether LepR deletion in osteocytes would rectify the Dmp1cre.Socs3fl/fl bone defect. First, we tested LepR deletion in osteocytes by generating Dmp1cre.LepRfl/fl mice and detected no significant bone phenotype. We then generated Dmp1cre.Socs3fl/fl.LepRfl/fl mice and compared them to Dmp1cre.Socs3fl/fl controls. Between 6 and 12 weeks of age, both Dmp1cre.Socs3fl/fl.LepRfl/fl and control (Dmp1cre.Socs3fl/fl) mice showed an increasing proportion of more heavily mineralised bone, indicating some cortical consolidation with time. However, at 12 weeks of age, rather than resolving the phenotype, delayed consolidation was extended in female Dmp1cre.Socs3fl/fl.LepRfl/fl mice. This was indicated in both metaphysis and diaphysis by greater proportions of low-density bone, lower proportions of high-density bone, and greater cortical porosity than Dmp1cre.Socs3fl/fl controls. There was also no change in the proportion of osteocytes staining positive for phospho-STAT3, suggesting the effect of LepR deletion in Dmp1cre.Socs3fl/fl mice is STAT3-independent. This identifies a new role for leptin signalling in bone which opposes our original hypothesis. Although LepR in osteocytes has no irreplaceable physiological role in normal bone maturation, when STAT3 is hyperactive, LepR in Dmp1Cre-expressing cells supports cortical consolidation.
骨强度部分取决于皮质骨的整合,这一过程包括周边骨小梁的融合及其渐进的矿化。信号转导和转录激活因子 3(STAT3)信号的抑制剂细胞因子信号转导抑制因子 3(SOCS3)基因缺失的小鼠表现出皮质骨整合延迟,表现为皮质骨孔隙率高、矿化含量低和骨强度低。由于瘦素受体(LepR)在成骨细胞谱系中表达,并被 SOCS3 抑制,我们评估了骨细胞中 LepR 的缺失是否会纠正 Dmp1cre.Socs3fl/fl 骨缺陷。首先,我们通过生成 Dmp1cre.LepRfl/fl 小鼠来测试骨细胞中的 LepR 缺失,并未检测到明显的骨表型。然后,我们生成了 Dmp1cre.Socs3fl/fl.LepRfl/fl 小鼠,并将其与 Dmp1cre.Socs3fl/fl 对照进行比较。在 6 至 12 周龄时,Dmp1cre.Socs3fl/fl.LepRfl/fl 和对照(Dmp1cre.Socs3fl/fl)小鼠均表现出越来越多的骨矿化程度较高的骨,表明随着时间的推移皮质骨有一定的整合。然而,在 12 周龄时,Dmp1cre.Socs3fl/fl.LepRfl/fl 雌性小鼠的整合延迟不仅没有得到解决,反而延长了。这在骺板和骨干中均表现为低密度骨的比例增加,高密度骨的比例减少,皮质骨孔隙率增加,与 Dmp1cre.Socs3fl/fl 对照相比。磷酸化 STAT3 染色阳性的成骨细胞比例也没有变化,这表明 Dmp1cre.Socs3fl/fl 小鼠中 LepR 缺失的作用与 STAT3 无关。这确定了瘦素信号在骨中的一个新作用,与我们最初的假设相反。虽然成骨细胞中的 LepR 在正常骨成熟中没有不可替代的生理作用,但当 STAT3 过度活跃时,Dmp1Cre 表达细胞中的 LepR 支持皮质骨整合。